tiprankstipranks

Peter N. Kellogg Insider Profile

4 Followers
Peter N. Kellogg, Director at Alnylam Pharma, holds 1.45K shares in Alnylam Pharma (Ticker: ALNY), holds 12.50K shares in Yield10 Bioscience (Ticker: YTENQ), holds 49.69K shares in Celgene (Ticker: CELG).
tipranks
Peter N. Kellogg

Peter N. Kellogg
Alnylam Pharma (ALNY)
Director

Not Ranked
Peter N. Kellogg has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$27M
83.10%
15.48%
1.42%
0.00%
A breakdown of Peter N. Kellogg's holdings

Insider Roles

Merck & Company
(MRK)
Exe V-P & CFO
Biogen
(BIIB)
EVP, Finance and CFO
Alnylam Pharma
(ALNY)
Director
Yield10 Bioscience
(YTENQ)
Director
Roles that Peter N. Kellogg holds in companies

Most Profitable Insider Trade

Stock:
Merck & Company
(MRK)
Rating:Informative Buy
Date:Aug 15, 2011 - Aug 15, 2012
Return:+43.50%
The most profitable trade made by Peter N. Kellogg

Peter N. Kellogg's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Alnylam Pharma
May 22, 2026
Director
Uninformative Buy
$384.80K
CELG
Celgene
Feb 16, 2017
Uninformative Buy
$5.38M
Yield10 Bioscience
Jul 05, 2017
Director
Uninformative Buy
Merck & Company
Feb 26, 2014
Exe V-P & CFO
Uninformative Buy
1.05M
$22.48M
Biogen
EVP, Finance and CFO
$4.19M
List of latest transactions for each holding click on a transaction to see Peter N. Kellogg's performance on stock

Peter N. Kellogg insider profile FAQ

What is the percentage of profitable transactions made by Peter N. Kellogg?
The percentage of profitable transactions made by Peter N. Kellogg is ―.
    What is the average return per transaction made by Peter N. Kellogg?
    The average return per transaction made by Peter N. Kellogg is ―.
      What stocks does Peter N. Kellogg hold?
      Peter N. Kellogg holds: ALNY, CELG, YTENQ, MRK, BIIB stocks.
        What was Peter N. Kellogg’s latest transaction?
        Peter N. Kellogg latest transaction was an Uninformative Buy of ―.
          What was Peter N. Kellogg's most profitable transaction?
          Peter N. Kellogg’s most profitable transaction was an Informative Buy of MRK stock on August 15, 2011. The return on the trade was 43.50%.
            What is Peter N. Kellogg's role in Alnylam Pharma?
            Peter N. Kellogg's role in Alnylam Pharma is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.